Zobrazeno 1 - 10 of 23 pro vyhledávání: '"J A, Kobashigawa"'
1
Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection
Autor: A R, Tambur, R A, Bray, S K, Takemoto, M, Mancini, M R, Costanzo, J A, Kobashigawa, C L, D'Amico, K R, Kanter, A, Berg, J D, Vega, A L, Smith, A L, Roggero, J W, Ortegel, L, Wilmoth-Hosey, J M, Cecka, H M, Gebel
Publikováno v: Transplantation. 70(7)
Historically, panel reactive antibody (PRA) analysis to detect HLA antibodies has been performed using cell-based complement-dependent cytotoxicity (CDC) techniques. Recently, a flow cytometric procedure (FlowPRA) was introduced as an alternative app
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7fee39897640ad6ee70bbb0fdeecf265
https://pubmed.ncbi.nlm.nih.gov/11045642
Zobrazit plný text záznamu
2
The University of California at Los Angeles experience in heart transplantation
Autor: J A, Kobashigawa, H, Laks, D, Marelli, J D, Moriguchi, M A, Hamilton, G, Fonarow, A, Hage, N, Kawata
Publikováno v: Clinical transplants.
In the last decade, the number of patients undergoing heart transplant has steadily increased as a result of expanding indications for this procedure. The limitation on the number of transplants performed has been the number of donor organs available
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f64d620902f096d3900a18279cf58ac6
https://pubmed.ncbi.nlm.nih.gov/10503108
Zobrazit plný text záznamu
4
The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro
Autor: S, Katznelson, X M, Wang, D, Chia, M, Ozawa, H P, Zhong, M, Hirata, P I, Terasaki, J A, Kobashigawa
Publikováno v: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 17(4)
We have reported that heart transplant recipients treated with pravastatin demonstrate decreases in the incidence of clinically severe acute rejection episodes, the incidence and progression of transplant coronary vasculopathy, and natural killer cyt
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ebf036374452e2ca0c1473e02b10c54e
https://pubmed.ncbi.nlm.nih.gov/9588577
Zobrazit plný text záznamu
5
The effect of pravastatin on acute rejection after kidney transplantation--a pilot study
Autor: S, Katznelson, A H, Wilkinson, J A, Kobashigawa, X M, Wang, D, Chia, M, Ozawa, H P, Zhong, M, Hirata, A H, Cohen, P I, Teraski
Publikováno v: Transplantation. 61(10)
Hyperlipidemia is an important complication of kidney transplantation affecting up to 74% of recipients. HMG-CoA reductase inhibitors are reported to provide safe and effective treatment for this problem. A recent study suggests that pravastatin, an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d51dd0ccb7595502d4e83ab528cfbb4b
https://pubmed.ncbi.nlm.nih.gov/8633373
Zobrazit plný text záznamu
6
Dual roles of HMG-CoA reductase inhibitors in solid organ transplantation: lipid lowering and immunosuppression
Autor: S, Katznelson, J A, Kobashigawa
Publikováno v: Kidney international. Supplement. 52
Hyperlipidemia has been associated with the development of transplant coronary vasculopathy (TCV) in heart transplant recipients and chronic rejection in kidney transplant recipients. HMG-CoA reductase inhibitors (HMGCoARIs) are effective in treating
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8c56e32964f5a23db57ef8ddd7f08b1b
https://pubmed.ncbi.nlm.nih.gov/8587272
Zobrazit plný text záznamu
10
Corticosteroid weaning late after heart transplantation: relation to HLA-DR mismatching and long-term metabolic benefits
Autor: J A, Kobashigawa, L W, Stevenson, E D, Brownfield, M P, Gleeson, J D, Moriguchi, N, Kawata, R, Minkley, D C, Drinkwater, H, Laks
Publikováno v: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 14(5)
To avoid the long-term side effects of corticosteroids, corticosteroid-free immunosuppression has been introduced immediately or late (more than 6 months) after heart transplantation. Late corticosteroid weaning may have a higher success rate as pati
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::598f8482df6c603a6f1cdce940dcaefa
https://pubmed.ncbi.nlm.nih.gov/8800734
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje